OMED - OncoMed Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts8888
Avg. Estimate-0.41-0.39-1.85-1.67
Low Estimate-0.56-0.52-2.38-2.4
High Estimate-0.32-0.32-1.66-0.64
Year Ago EPS-0.77-0.6-3.14-1.85
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts8888
Avg. Estimate5.12M4.94M22.5M31.03M
Low EstimateN/AN/A12.41M18M
High Estimate7.6M6.3M26.4M49.48M
Year Ago Sales5.92M6.22M25.15M22.5M
Sales Growth (year/est)-13.50%-20.60%-10.50%37.90%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-0.77-0.68-0.63-0.5
EPS Actual-0.77-0.6-0.61-0.4
Difference00.080.020.1
Surprise %0.00%11.80%3.20%20.00%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.41-0.39-1.85-1.67
7 Days Ago-0.41-0.39-1.85-1.67
30 Days Ago-0.41-0.39-1.85-1.67
60 Days Ago-0.41-0.39-1.85-1.67
90 Days Ago-0.4-0.38-1.9-1.7
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesOMEDIndustrySectorS&P 500
Current Qtr.46.80%N/AN/A0.16
Next Qtr.35.00%N/AN/A0.27
Current Year41.10%N/AN/A0.07
Next Year9.70%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A